Status:
COMPLETED
Detection of LADA in a Hospital in the Mexican Southeast
Lead Sponsor:
Universidad Juárez Autónoma de Tabasco
Conditions:
Latent Autoimmune Diabetes
Eligibility:
All Genders
30-50 years
Brief Summary
Patients with Latent Autoimmune Diabetes in Adults (LADA) show autoantibodies that indicate an autoimmune pathogenesis. Glutamic acid decarboxylase autoantibodies (GADA) are most prevalent islet autoa...
Eligibility Criteria
Inclusion
- patients previously diagnosed with T2D,
- absence of insulin requirement for at least 6 months after diagnosis,
- \> 30 and \< 50 years old at diabetes diagnosis,
- BMI \< 40 kg/m2,
- subjects who agreed to participate in the study and signed the informed consent before the interview.
Exclusion
- • patients with other types of diabetes, and subjects who did not agree to participate.
Key Trial Info
Start Date :
January 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05235672
Start Date
January 30 2021
End Date
December 30 2021
Last Update
February 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Isela Esther Juarez Rojop
Villahermosa, Tabasco, Mexico, 86090